NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/21/2026
Back to search
Official data from USPTO
CHONG KUN DANG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CHONG KUN DANG
ST13
US500000088470347Class
5
Filing
88470347
Registration
6166899
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/21/2026
Trademark type
Word
Nice classes
5
Filing date
06/12/2019
Registration date
10/06/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Seoul, KR
Examiner
LEVINE, HOWARD B
Current location
Historical data usage
Holders and representatives
Holders
CHONG KUN DANG HOLDINGS CORP.
Representatives
Michael T. Smith BIRCH, STEWART, KOLASCH & BIRCH, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vitamin preparations; Antibiotic preparations; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating respiratory diseases; Allergy medications; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Cardiovascular agents for medical purposes; Amino acids for medical purposes; Dermatological pharmaceutical preparations; Ophthalmic preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparationsantivirals; Tumor suppressing agents; Pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of hyperlipidemia; Anti-inflammatories; Analgesics; Bacterial poisons; Pharmaceutical preparations for the treatment of cellular disorders; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for use in urology; Vaccines; Nutritional supplementstonics and alternatives for medical purposes; Antibiotics; pharmaceutical preparation for the arthritis treatment; pharmaceutical preparation for the rheumarthritis treatment; Anti-cancer preparations; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Health food supplement mainly based on lactic acid bacteria; Nutritional supplementsprobiotic compositions; Lactic acid bacteria in the form of capsules for medical purpose; Lactose for medical purposes; Powdered milk for babies; Calcium supplements; Powdered nutritional supplement drink mixes; Probiotic supplements; Pharmaceutical preparations for use in the treatment of diabetesanemiacardiovascular diseaseweight losshormone replacementnutritional deficienciesinfectious diseaseautoimmune diseasefatigueinflammationpainenvironmental toxicitiesheavy metal toxicities; Nutraceutical preparations for therapeutic or medical purposes in the treatment of gout; nutraceuticals for use as a dietary supplement; Anti-oxidant food supplements; Food supplementsanti-oxidants; Food supplements ; Dietary supplements; Medicated food supplements
Publications
History of USPTO decisions and trademark events.
30 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/21/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/21/2026
E815
TEAS SECTION 8 & 15 RECEIVED
04/16/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/06/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/02/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/02/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/02/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/21/2020
PUBO
PUBLISHED FOR OPPOSITION
07/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/10/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/01/2020
GNSL
LETTER OF SUSPENSION E-MAILED
04/01/2020
CNSL
SUSPENSION LETTER WRITTEN
04/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2020
ALIE
ASSIGNED TO LIE
03/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/05/2019
GNRT
NON-FINAL ACTION E-MAILED
09/05/2019
CNRT
NON-FINAL ACTION WRITTEN
09/05/2019
DOCK
ASSIGNED TO EXAMINER
09/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/25/2019
NWAP
NEW APPLICATION ENTERED
06/15/2019
Continuous trademark protection
Get notified about every new filing that threatens CHONG KUN DANG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.